Skip to main content
MDLN logo

MDLN · Medline Inc. · Earnings Call Transcripts & Audio

Track MDLN — free
$34.80 +0.10 (+0.29%)
Market Cap
$45.62B
Shares
1.31B
Volume · Sep 30 9.1M Avg daily vol (3M) 7.46M

Medline Inc. Earnings Call Transcripts

Quarterly earnings calls for Medline Inc. (MDLN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
Conference
Investor event
2026-09-15
Medline Inc. (MDLN) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
Medline Inc. (MDLN) Q2 2026 Earnings Call Transcript
Positive tone Prime vendor and customer signings Organic sales growth and raised outlook Distribution network expansion in California
Revenue
$7.68B
▲ 11.6% YoY
Diluted EPS
$0.07
Gross margin
28.8%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-09
Medline Inc. (MDLN) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Medline Inc. (MDLN) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-06
Medline Inc. (MDLN) Q1 2026 Earnings Call Transcript
Positive tone Medline brand and multi-sourcing resilience Top-line growth and customer wins Tariffs and cost pressure
Revenue
$7.35B
▲ 10.7% YoY
Diluted EPS
$0.16
Gross margin
25.0%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-11
Medline Inc. (MDLN) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-02-25
Medline Inc. (MDLN) Q4 2025 Earnings Call Transcript
Confident tone Revenue and Sales Growth Medline Brand Portfolio and Product Innovation IPO and Balance Sheet Strength
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–7 of 7 earnings calls
Key facts CIK 2046386 CUSIP 58507V107 13F (30d) 10 filings 10 filers Visit website Investor relations